Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries has informed that one of the wholly owned subsidiaries of the Company has acquired 13,000,000 Series B Preferred Stock of scPharmaceuticals Inc. (equivalent to 14.58% fully diluted equity stake on conversion) by way of allotment. scPharmaceuticals Inc., is a United States pharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.

The above information is a part of company’s filings submitted to BSE.